31st May 2024
- 0 comments
USA: S2N Health, Inc. has successfully secured seed funding to fuel the growth of the company’s RepSignalTM medtech customer intelligence SaaS platform, and to develop a robust roadmap of AI-powered solutions for accelerating the market impact of healthcare technologies. The round was led by Excelerate Health Ventures, a premier digital health fund focused on healthcare software and technology-enabled services, with participation from other established healthcare and technology investors, including Boston Millennia Partners and Robin Hood Ventures.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.